An appeal before the New Jersey Supreme Court over expert testimony in suits concerning the acne drug Accutane is seen by many as a chance to revise the state’s standard for admitting such evidence.
Lawyers for drugmaker Hoffmann-La Roche have asked the court to consider whether a trial judge exceeded his authority by excluding two expert witnesses for the plaintiffs based on a conclusion that their views lacked support in the scientific community. That decision was later overturned by the Appellate Division, which reinstated 2,100 plaintiffs’ suits based on its finding that the judge below went beyond his role as gatekeeper.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
